DENK NUTRITION
LIVE

Serial Number

79198538

Owner

DENK PHARMA GmbH & Co. KG

Attorney

Scott Greenberg

Filing Date

Aug 3, 2016

Add to watchlist:

No watchlists yet
View on USPTO

DENK NUTRITION Trademark

Serial Number: 79198538 • Registration: 5445435

DENK NUTRITION is a trademark filed by DENK PHARMA GmbH & Co. KG on August 3, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

DENK PHARMA GmbH & Co. KG (3 trademarks)

Prinzregentenstr. 79

Entity Type: 28

Trademark Details

Filing Date

August 3, 2016

Registration Date

April 17, 2018

Published for Opposition

January 30, 2018

Cancellation Date

November 1, 2024

Goods & Services

Pharmaceutical preparations and chemical preparations for medical purposes for the treatment of diseases and conditions of alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genito-urinary system and sex hormones, antiinfectives for systemic use, musculo-skeletal system, nervous system and respiratory system; healthcare preparations, namely, food supplements and medical preparations for the treatment of disturbances with and support of digestive enzymes, for optimizing the supply of nutrients to mother and child, for the promotion of fertility, for the relief and elimination of lactose intolerance, for the development of teeth, bones and muscles growth, for care during pregnancy and breastfeeding, for supporting the memory, concentration and learning, for the care of the immune system, for the strengthening and maintenance of joints, cartilage, bones and muscles, for the magnesium supply of heart, nerves and muscles, for increasing the iron requirement, for increasing the sperm formation and for the folic acid care before and during pregnancy; dietetic preparations for medical purposes in the form of vitamins, mineral nutrients, trace elements, proteins and carbohydrates; food supplements for medical and non-medical purposes, namely, for the treatment of disturbances with and support of digestive enzymes, for optimizing the supply of nutrients to mother and child, for the promotion of fertility, for the relief and elimination of lactose intolerance, for the development of teeth, bones and muscles growth, for care during pregnancy and breastfeeding, for supporting the memory, concentration and learning, for the care of the immune system, for the strengthening and maintenance of joints, cartilage, bones and muscles, for the magnesium supply of heart, nerves and muscles, for increasing the iron requirement, for increasing the sperm formation and for the folic acid care before and during pregnancy

Wholesale and retail store services featuring pharmaceutical and chemical preparations used in industry, science, agriculture, horticulture and forestry, especially for use in the foodstuff, food supplement, pharmaceutical and cosmetics industries

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Dec 25, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 6, 2025 INTS
INVALIDATION PROCESSED
Dec 6, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 1, 2025 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2025 NREP
CANCELLED SECTION 71
Nov 1, 2024 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Jun 10, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 10, 2023 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 17, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 31, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 1, 2018 FICS
FINAL DISPOSITION PROCESSED
Aug 1, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 17, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 17, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 30, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Jan 26, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 10, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 10, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 20, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 20, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 20, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 20, 2017 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 7, 2017 GNRN
NON-FINAL ACTION E-MAILED
Nov 7, 2017 GNRT
NON-FINAL ACTION WRITTEN
Nov 7, 2017 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 3, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 31, 2017 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 12, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 12, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 12, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 12, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 9, 2017 GNRN
NON-FINAL ACTION E-MAILED
Aug 9, 2017 GNRT
NON-FINAL ACTION WRITTEN
Aug 9, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2017 CRFA
ASSIGNED TO LIE
Aug 4, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2017 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Apr 13, 2017 NREP
REFUSAL PROCESSED BY IB
Jan 27, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 9, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jan 9, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 29, 2016 RFCR
NON-FINAL ACTION WRITTEN
Dec 28, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 27, 2016 MAFR
ASSIGNED TO EXAMINER
Dec 23, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 23, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 22, 2016 REPR